For Use in the United States Only
  • About
    • Leadership
    • Medical Advisory Board
    • In the News
    • Contact Us
  • Dry Eye
  • Product Information
    • Instructions for Use
    • How to Administer Video
    • Clinical Trial and Product Data
    • Frequently Asked Questions
  • Eye Care Professionals
    • Reimbursement
  • Resources
    • Administration Techniques
    • Educational Series Webinars
    • Resource Library
  • Pay Now
  • Contact Us
PAY NOW
Contact Us

In the News

LACRIFILL® Canalicular Gel is changing clinical practice and changing lives when it comes to dry eye treatment.
Latest News

Nordic Group B.V. Through Its Subsidiary Nordic Pharma, Inc. (U.S.), to Present Data on LACRIFILL® Canalicular Gel, a Novel Therapy for Dry Eye, at the American Society of Cataract and Refractive Surgery Annual Meeting

04/02/24

read more

Nordic Group B.V. Through Its Subsidiary Nordic Pharma, Inc. (U.S.), Appoints Renowned Oculoplastic Surgeon, John P. Fezza, MD to Its Medical Advisory Board

03/14/24

read more

Amring Pharmaceuticals Inc. announces name change to Nordic Pharma, Inc. under new Nordic Group, B.V. ownership

03/04/24

read more

Nordic Group B.V. through its subsidiary Amring Pharmaceuticals Inc., appoints ophthalmology innovator, Eric D. Donnenfeld, MD as Medical Advisory Board Chair

02/26/24

read more
« Older Entries
Next Entries »


Come meet with us at these 2025 Meetings and Conferences

Kiawah Eye
May 29-31 | Kiawah Island, SC

AOA: Optometry's Meeting
June 25-28 | Minneapolis, MN

Ophthalmology Tech Forum
June 26-27 | Newport Beach, CA

AECOS Summer Symposium
July 10-13 | Deer Valley, UT

Women in Ophthalmology (WIO)
August 7-10 | Amelia Island, FL

  • Dry Eye
  • Eye Care Professionals
  • In the News
  • Contact Us
  • Privacy Policy
  • Terms & Conditions

For Use in the United States Only

©2025 Nordic Pharma, Inc. All rights reserved. LACRIFILL® is a registered trademark of Nordic Pharma, Inc. U.S. Pat. Nos. 8,979,821 and 9,504,605